The Right TraderBeta

Cartesian Therapeutics, Inc.

RNAC
—
Advanced chart & tools →
Cartesian Therapeutics, Inc.RNAC
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-5.02
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$400,000
Net income
$-130.30M
Net margin
-32575.5%
Gross margin
—

Dividends & financials

Cartesian Therapeutics, Inc. (RNAC) reported revenue of $400,000 and net income of $-130.30M, or $-5.02 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.